Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells

Blood (2014) 124 (21): 624.

https://doi.org/10.1182/blood.V124.21.624.624

Published: 2014

Journal Articles

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

Enrico Derenzini, MD, Cinzia Pellegrini, MD, Roberto Maglie, Vittorio Stefoni, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Beatrice Casadei, MD, Federica Quirini, MD, Lisa Argnani, PhD, Stefano Fanti, MD, Maria Rosa Motta, PhD, Michele Baccarani, MD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 3019.

https://doi.org/10.1182/blood.V120.21.3019.3019

Published: 2012

Journal Articles

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

Antonio Curti, Loredana Ruggeri, Alessandra D'Addio, Andrea Bontadini, Elisa Dan, Maria Rosa Motta, Sara Trabanelli, Valeria Giudice, Elena Urbani, Giovanni Martinelli, Stefania Paolini, Fiorenza Fruet, Alessandro Isidori, Sarah Parisi, Giuseppe Bandini, Michele Baccarani, Andrea Velardi, Roberto M. Lemoli

Blood (2011) 118 (12): 3273–3279.

https://doi.org/10.1182/blood-2011-01-329508

Published: 2011

Includes: Supplemental data

Journal Articles

CD133 + Pluripotent Stem Cells for the Treatment of Chronic Liver Failure.

Lucia Catani, BS, Stefania Lorenzini, MD, Rosaria Giordano, MD, Paolo Caraceni, MD, Maria Rosa Motta, BS, Valeria Giudice, MD, Tiziana Montemurro, MD, Ferdinando Giannone, MD, Daria Sollazzo, Elisa Dan, BS, Benedetta Nicolini, BS, Francesca Chelli, Michele Baccarani, MD, Mauro Bernardi, MD, Francesco Losinno, MD, Pietro Andreone, MD, Roberto M. Lemoli, MD

Blood (2010) 116 (21): 1185.

https://doi.org/10.1182/blood.V116.21.1185.1185

Published: 2010

Journal Articles

Adoptive Immunotherapy with Haploidentical Kir Ligand-Mismatched Natural Killer Cells In Elderly High Risk Acute Myeloid Leukemia Patients: Biological and Clinical Results of A Pilot Study

Antonio Curti, PhD, Loredana Ruggeri, PhD, Alessandra D'Addio, Andrea Bontadini, PhD, Valeria Giudice, PhD, Elisa Dan, PhD, Maria Rosa Motta, PhD, Simonetta Rizzi, Sara Trabanelli, PhD, Elena Urbani, PhD, Giovanni Martinelli, PhD, Stefania Paolini, PhD, Fiorenza Fruet, PhD, Alessandro Isidori, Beatrice Casadei, PhD, Giuseppe Bandini, PhD, Michele Baccarani, PhD, Andrea Velardi, PhD, Roberto M. Lemoli

Blood (2010) 116 (21): 4287.

https://doi.org/10.1182/blood.V116.21.4287.4287

Published: 2010

Journal Articles

The Addition of Plerixafor Allows Adequate PBSC Collection in Multiple Myeloma and Lymphoma Patients Poor –mobilizers After Chemotherapy and G-CSF.

Alessandra D'Addio, MD, Antonio Curti, MD, Valeria Giudice, MD, Maria Rosa Motta, Simona Rizzi, Elisa Dan, Simona Taioli, Michele Baccarani, MD, Roberto M Lemoli, MD

Blood (2009) 114 (22): 3233.

https://doi.org/10.1182/blood.V114.22.3233.3233

Published: 2009

Journal Articles

Phase I-II Trial of Adoptive Immunotherapy with Haploidentical KIR Ligand-Mismatched Natural Killer Cells in High Risk Acute Myeloblastic Leukemia Patients.

Antonio Curti, MD, Loredana Ruggeri, BS, Alessandra D’Addio, MD, Elena Urbani, BS, Andrea Bontadini, MD, Fiorenza Fruet, BS, Valeria Giudice, MD, Elisa Dan, BS, Maria Rosa Motta, BS, Simona Rizzi, BS, Stefania Paolini, MD, Gabriele Gugliotta, MD, Roberto Conte, MD, Giovanni Martinelli, MD, Andrea Velardi, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2007) 110 (11): 2857.

https://doi.org/10.1182/blood.V110.11.2857.2857

Published: 2007

Journal Articles

Phase II Study of a Single Pegfilgrastim Injection as Adjunct to Chemotherapy to Mobilize Stem Cells into Peripheral Blood of Resistant/Relapsed Lymphoma Patients.

Roberto M. Lemoli, MD, Alessandro Isidori, MD, Monica Tani, MD, Francesca Bonifazi, MD, Pier Luigi Zinzani, MD, Antonio Curti, MD, Maria Rosa Motta, BS, Simonetta Rizzi, BS, Valeria Giudice, MD, Oriana Farese, BS, Manuela Rovito, BS, Lapo Alinari, MD, Roberto Conte, MD, Michele Baccarani, MD

Blood (2004) 104 (11): 2871.

https://doi.org/10.1182/blood.V104.11.2871.2871

Published: 2004

Journal Articles

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy

Roberto M. Lemoli, Giovanni Martinelli, Elena Zamagni, Maria Rosa Motta, Simonetta Rizzi, Carolina Terragna, Roberto Rondelli, Sonia Ronconi, Antonio Curti, Francesca Bonifazi, Sante Tura, Michele Cavo

Blood (2000) 95 (7): 2234–2239.

https://doi.org/10.1182/blood.V95.7.2234

Published: 2000

NARROW

Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

CD133 + Pluripotent Stem Cells for the Treatment of Chronic Liver Failure.

Adoptive Immunotherapy with Haploidentical Kir Ligand-Mismatched Natural Killer Cells In Elderly High Risk Acute Myeloid Leukemia Patients: Biological and Clinical Results of A Pilot Study

The Addition of Plerixafor Allows Adequate PBSC Collection in Multiple Myeloma and Lymphoma Patients Poor –mobilizers After Chemotherapy and G-CSF.

Phase I-II Trial of Adoptive Immunotherapy with Haploidentical KIR Ligand-Mismatched Natural Killer Cells in High Risk Acute Myeloblastic Leukemia Patients.

Phase II Study of a Single Pegfilgrastim Injection as Adjunct to Chemotherapy to Mobilize Stem Cells into Peripheral Blood of Resistant/Relapsed Lymphoma Patients.

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only